When was PneumRx founded?

PneumRx was founded in 2004 and raised its 1st funding round 1 year after it was founded.

Where is PneumRx located?

PneumRx is headquartered in Mountain View, United States. It is registered at Santa Clara, California.

How many employees does PneumRx have?

As of Dec 31, 2019, PneumRx has 7 employees, reflecting a 84% year-over-year decline in headcount.

Is PneumRx a funded company?

PneumRx is a funded company, having raised a total of $49.6M across 3 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Jun 14, 2005.

When was the latest funding round of PneumRx?

PneumRx's latest funding was a $***** Series C round on Dec 30, 2010, with participation from 8 investors. Its primary sector is Pulmonology. In United States, the Pulmonology sector has seen $962M in funding in 2026 to date.

Where does PneumRx rank among its competitors?

PneumRx ranks 8th amongst 15 active competitors, of which 4 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Selio Medical, which secured $2.51M in Jul, 2022.

Who are the top competitors of PneumRx?

PneumRx's top competitors include Pulmonx, Novate Medical and Spiration. Among them, Selio Medical secured the most recent funding round in July, 2022.

PneumRx - 2026 Company Profile, Team, Funding & Competitors

Q: Is PneumRx an acquired company?

PneumRx got acquired by BTG International on Dec 04, 2014.

Company Details

Medical solutions innovator dedicated to transforming lives through science. The company advances science for life, providing a wide array of medical devices and therapies for healthcare professionals and patients. It focuses on multiple medical specialties, including cardiology, gastroenterology, urology, and more. The company offers products, treatments, and support for various conditions, including cancer, heart and vascular diseases, and neurological conditions. It provides device support, professional education, and resources for both healthcare providers and individuals seeking medical information. The company is committed to corporate responsibility, innovation, and improving patient health globally. It offers career opportunities and investor relations information, emphasizing its dedication to advancing healthcare solutions.

Website: pneumrx.com
Registered Address: Santa Clara, California

Key Metrics

Founded Year

2004

Location

Mountain View, United States

Stage

Acquired

Total Funding

$49.6M in 3 rounds

Latest Funding Round

Series C, Dec 30, 2010, $*****

Investors

Adams Street Partners & 11 more

Ranked

8^th among 15 active competitors

Employee Count

7 as on Dec 31, 2019

Similar Companies

Pulmonx & 22 more

Exit Details

Acquired by BTG International (Dec 04, 2014)

View PneumRx's full profile

PneumRx is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
PNEUMRX INC CIN: 562459462 , United States, Active	Dec 31, 1999	-	2 (As on Dec 31, 2021)	-

PneumRx got acquired by BTG International on Dec 04, 2014 at an acquisition amount of $*****.

Click here to take a look at PneumRx's acquisition in detail

PneumRx has raised a total funding of $49.6M over 3 rounds. Its first funding round was on Jun 14, 2005. Its latest funding round was a Series C round on Dec 30, 2010 for $*****. 8 investors participated in its latest round. PneumRx has 12 institutional investors.

Here is the list of recent funding rounds of PneumRx:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 30, 2010	5176622	Series C	8257737	5469354	4398139	1347080
Mar 05, 2007	8197661	Series B	4338657	2015908	9112364	Alta Partners & 3 more
Jun 14, 2005	7694396	Series A	8897255	1109841	4265950	7750555

Access funding benchmarks and valuations. Sign up today!

View details of PneumRx's funding rounds and investors

The founders of PneumRx is Erin Mcgurk.

Here are the details of PneumRx's key team members:

Erin Mcgurk: Former Co-Founder of PneumRx.

View details of PneumRx's Founder profiles and Board Members

PneumRx's employee count trend

PneumRx has 7 employees as of Dec 19. The total employee count is 84.0% lower than what it was in Dec 18. Here is PneumRx's employee count trend over the years:

Uncover PneumRx's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of PneumRx include Pulmonx, Novate Medical and Spiration. Here is the list of Top 10 competitors of PneumRx, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Pulmonx 1998, Redwood City (United States), Public	Developer of smart devices for treating pulmonary diseases	$281M	Ally Bridge Group, Kleiner Perkins & 18 others	71/100
2nd	Novate Medical 2006, Galway (Ireland), Acquired	Provider of inferior vena cava filter for treatment of pulmonary embolism	$18M	Seroba Life Sciences, Omnes Capital & 2 others	46/100
3rd	Spiration 1999, Redmond (United States), Acqui-Hired	Emphysema treatment using minimally invasive Spiration Valve System to improve life	$73.9M	Versant Ventures, Investor Growth Capital ... & 8 others	43/100
4th	Uptake Medical 2005, Tustin (United States), Acquired	Medical device company improving lives through vapor ablation for pulmonary disease	$71.7M	Maverick Ventures, Prism Venture Partners ... & 8 others	38/100
5th	Medos AG 1978, Stolberg (Germany), Acquired	Range of product and therapy solutions for cardiac surgeons and perfusionists.	-	-	37/100
6th	Selio Medical 2016, Dublin (Ireland), Seed	Developer of device to prevent pneumothorax during transthoracic needle biopsy	-	EIC Fund, MedTech Innovator & 1 others	34/100
7th	Sanovas 2009, San Rafael (United States), Series A	Platform of tools for interventional therapeutics and diagnostic applications in various specialties	$9.52M	-	34/100
8th	PneumRx 2004, Mountain View (United States), Acquired	Medical solutions innovator dedicated to transforming lives through science	$49.6M	Adams Street Partners, KBL & 10 others	33/100
9th	Lumeda 2020, Rocky Hill (United States), Series A	Developer of photodynamic therapy device for treating lung cancer	$5.34M	Connecticut Innovations, Cycle Capital	33/100
10th	Vascular Architects 1999, San Jose (United States), Acqui-Hired	Developer of devices for the treatment of peripheral vascular disease and nonvascular obstructions	$55M	Domain Associates, Medtronic & 7 others	32/100